141 related articles for article (PubMed ID: 2901381)
1. Potential use of drugs modulating 5HT activity in the treatment of anxiety.
Gardner CR
Gen Pharmacol; 1988; 19(3):347-56. PubMed ID: 2901381
[TBL] [Abstract][Full Text] [Related]
2. Selective activation of 5HT1A receptors induces lower lip retraction in the rat.
Berendsen HH; Jenck F; Broekkamp CL
Pharmacol Biochem Behav; 1989 Aug; 33(4):821-7. PubMed ID: 2533357
[TBL] [Abstract][Full Text] [Related]
3. Recent developments in 5HT-related pharmacology of animal models of anxiety.
Gardner CR
Pharmacol Biochem Behav; 1986 May; 24(5):1479-85. PubMed ID: 2873594
[TBL] [Abstract][Full Text] [Related]
4. RU24969-induced behavioural syndrome requires activation of both 5HT1A and 5HT1B receptors.
O'Neill MF; Parameswaran T
Psychopharmacology (Berl); 1997 Aug; 132(3):255-60. PubMed ID: 9292625
[TBL] [Abstract][Full Text] [Related]
5. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
6. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
Meller E; Goldstein M; Bohmaker K
Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
[TBL] [Abstract][Full Text] [Related]
7. Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam.
Moser PC; Tricklebank MD; Middlemiss DN; Mir AK; Hibert MF; Fozard JR
Br J Pharmacol; 1990 Feb; 99(2):343-9. PubMed ID: 1970269
[TBL] [Abstract][Full Text] [Related]
8. Influence of forced swimming-induced stress on the anxiolytic-like effect of 5HT(1A) agents in mice.
Briones-Aranda A; López-Rubalcava C; Picazo O
Psychopharmacology (Berl); 2002 Jul; 162(2):147-55. PubMed ID: 12110992
[TBL] [Abstract][Full Text] [Related]
9. The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agents.
Dekeyne A; Brocco M; Adhumeau A; Gobert A; Millan MJ
Psychopharmacology (Berl); 2000 Sep; 152(1):55-66. PubMed ID: 11041316
[TBL] [Abstract][Full Text] [Related]
10. Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test.
Söderpalm B; Hjorth S; Engel JA
Pharmacol Biochem Behav; 1989 Jan; 32(1):259-65. PubMed ID: 2567524
[TBL] [Abstract][Full Text] [Related]
11. Modulation of rhythmic swimming activity in post-embryonic Xenopus laevis tadpoles by 5-hydroxytryptamine acting at 5HT1a receptors.
Wedderburn JF; Sillar KT
Proc Biol Sci; 1994 Jul; 257(1348):59-66. PubMed ID: 8090792
[TBL] [Abstract][Full Text] [Related]
12. Inhibition by 8-hydroxy-2-(di-n-propylamino) tetralin and SM-3997, a novel anxiolytic drug, of the hippocampal rhythmical slow activity mediated by 5-hydroxytryptamine1A receptors.
Hirose A; Tsuji R; Shimizu H; Tatsuno T; Tanaka H; Kumasaka Y; Nakamura M
Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):8-13. PubMed ID: 1969119
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of serotonergic affect control.
Kennett GA
Adv Exp Med Biol; 1991; 294():231-43. PubMed ID: 1685293
[No Abstract] [Full Text] [Related]
14. Contractile serotonergic receptor in rat stomach fundus.
Cohen ML; Fludzinski LA
J Pharmacol Exp Ther; 1987 Oct; 243(1):264-9. PubMed ID: 3668856
[TBL] [Abstract][Full Text] [Related]
15. Serotonergic modulation of the rat pup ultrasonic isolation call: studies with 5HT1 and 5HT2 subtype-selective agonists and antagonists.
Winslow JT; Insel TR
Psychopharmacology (Berl); 1991; 105(4):513-20. PubMed ID: 1771219
[TBL] [Abstract][Full Text] [Related]
16. Effects of the novel anxiolytics gepirone, buspirone and ipsapirone on free feeding and on feeding induced by 8-OH-DPAT.
Gilbert F; Dourish CT
Psychopharmacology (Berl); 1987; 93(3):349-52. PubMed ID: 2893412
[TBL] [Abstract][Full Text] [Related]
17. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
Goodwin GM; Green AR
Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat.
Dreteler GH; Wouters W; Saxena PR
Eur J Pharmacol; 1990 May; 180(2-3):339-49. PubMed ID: 2142096
[TBL] [Abstract][Full Text] [Related]
19. Effect of chronic treatment with 5-HT1 agonist (8-OH-DPAT and RU 24969) and antagonist (isapirone) drugs on the behavioural responses of mice to 5-HT1 and 5-HT2 agonists.
De Souza RJ; Goodwin GM; Green AR; Heal DJ
Br J Pharmacol; 1986 Oct; 89(2):377-84. PubMed ID: 2946344
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo.
Aune TM; Golden HW; McGrath KM
J Immunol; 1994 Jul; 153(2):489-98. PubMed ID: 8021490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
